Suppr超能文献

轻度饮酒习惯是非酒精性脂肪性肝病伴进展性肝纤维化患者发生肝癌的一个危险因素。

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.

机构信息

Department of Internal Medicine, Division of Gastroenterology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan.

出版信息

World J Gastroenterol. 2018 Apr 7;24(13):1440-1450. doi: 10.3748/wjg.v24.i13.1440.

Abstract

AIM

The impact of mild drinking habit (less than 20 g/d of ethanol) on the clinical course of non-alcoholic fatty liver disease (NAFLD) has not been determined. We examined the influence of a mild drinking habit on liver carcinogenesis from NAFLD.

METHODS

A total of 301 patients who had been diagnosed as having NAFLD by liver biopsy between 2003 and 2016 [median age: 56 years, 45% male, 56% with non-alcoholic steatohepatitis, 26% with advanced fibrosis (F3-4)] were divided into the mild drinking group with ethanol consumption of less than 20 g/d (mild drinking group, = 93) and the non-drinking group ( = 208). Clinicopathological features at the time of liver biopsy and factors related to hepatocellular carcinoma (HCC) occurrence were compared between the groups.

RESULTS

We observed significant differences in male prevalence ( = 0.01), platelet count ( = 0.04), and gamma-glutamyl transpeptidase ( = 0.02) between the test groups. Over 6 years of observation, the HCC appearance rate was significantly higher in the mild drinking group (6.5% 1.4%, = 0.02). Multivariate survival analysis using Cox's regression model revealed that hepatic advanced fibrosis (F3-4) ( < 0.01, risk ratio: 11.60), diabetes mellitus ( < 0.01, risk ratio: 89.50), and serum triglyceride ( = 0.04, risk ratio: 0.98) were factors significantly related to HCC in all NAFLD patients, while the effect of a drinking habit was marginal ( = 0.07, risk ratio: 4.43). In patients with advanced fibrosis (F3-4), however, a drinking habit ( = 0.04, risk ratio: 4.83), alpha-fetoprotein ( = 0.01, risk ratio: 1.23), and diabetes mellitus ( = 0.03, risk ratio: 12.00) were identified as significant contributors to HCC occurrence.

CONCLUSION

A mild drinking habit appears to be a risk factor for hepatocarcinogenesis in NAFLD patients, especially those with advanced fibrosis.

摘要

目的

轻度饮酒习惯(每天乙醇摄入量<20g)对非酒精性脂肪性肝病(NAFLD)临床病程的影响尚未确定。本研究旨在探讨轻度饮酒习惯对由 NAFLD 导致的肝癌发生的影响。

方法

2003 年至 2016 年间,通过肝活检诊断为 NAFLD 的 301 例患者[中位年龄:56 岁,45%为男性,56%为非酒精性脂肪性肝炎,26%为晚期纤维化(F3-4)],将其分为乙醇摄入量<20g/d 的轻度饮酒组(轻度饮酒组,n=93)和非饮酒组(n=208)。比较两组患者肝活检时的临床病理特征及与肝细胞癌(HCC)发生相关的因素。

结果

两组间男性患病率(P=0.01)、血小板计数(P=0.04)和γ-谷氨酰转肽酶(P=0.02)存在显著差异。在 6 年的观察期间,轻度饮酒组 HCC 发生率明显更高(6.5% vs. 1.4%,P=0.02)。多因素生存分析采用 Cox 回归模型显示,肝纤维化晚期(F3-4)(P<0.01,风险比:11.60)、糖尿病(P<0.01,风险比:89.50)和血清三酰甘油(P=0.04,风险比:0.98)是所有 NAFLD 患者 HCC 的显著相关因素,而饮酒习惯的影响具有边缘意义(P=0.07,风险比:4.43)。然而,在纤维化晚期(F3-4)的患者中,饮酒习惯(P=0.04,风险比:4.83)、甲胎蛋白(P=0.01,风险比:1.23)和糖尿病(P=0.03,风险比:12.00)是 HCC 发生的显著因素。

结论

轻度饮酒习惯似乎是 NAFLD 患者发生肝癌的危险因素,尤其是纤维化晚期的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3f2/5889824/1dee1b2631ea/WJG-24-1440-g001.jpg

相似文献

1
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
World J Gastroenterol. 2018 Apr 7;24(13):1440-1450. doi: 10.3748/wjg.v24.i13.1440.
3
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
J Gastroenterol Hepatol. 2019 Sep;34(9):1626-1632. doi: 10.1111/jgh.14608. Epub 2019 Mar 6.
4
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239.
5
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
7
The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis.
J Gastroenterol Hepatol. 2020 May;35(5):862-869. doi: 10.1111/jgh.14867. Epub 2019 Dec 3.
9
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11.

引用本文的文献

1
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.
J Can Assoc Gastroenterol. 2024 Aug 9;7(5):331-345. doi: 10.1093/jcag/gwae025. eCollection 2024 Oct.
3
The importance of patient engagement in the multimodal treatment of MASLD.
Commun Med (Lond). 2025 May 1;5(1):148. doi: 10.1038/s43856-025-00871-1.
5
MetALD: Clinical aspects, pathophysiology and treatment.
JHEP Rep. 2024 Nov 2;7(2):101250. doi: 10.1016/j.jhepr.2024.101250. eCollection 2025 Feb.
6
Hormone replacement therapy for steatotic liver management after surgical menopause.
Clin J Gastroenterol. 2025 Apr;18(2):352-356. doi: 10.1007/s12328-024-02090-y. Epub 2025 Jan 6.
8
10
Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B.
Int J Gen Med. 2024 Jun 25;17:2877-2886. doi: 10.2147/IJGM.S464083. eCollection 2024.

本文引用的文献

1
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame.
Cancers (Basel). 2017 Sep 25;9(10):130. doi: 10.3390/cancers9100130.
2
Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3170-3182. doi: 10.1016/j.bbadis.2017.08.017. Epub 2017 Aug 24.
3
Association between lower air pressure and the onset of ischemic colitis: a case-control study.
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1071-1078. doi: 10.1097/MEG.0000000000000913.
4
Targeting nuclear receptors for the treatment of fatty liver disease.
Pharmacol Ther. 2017 Nov;179:142-157. doi: 10.1016/j.pharmthera.2017.05.011. Epub 2017 May 23.
5
Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
World J Gastroenterol. 2017 Jan 28;23(4):712-722. doi: 10.3748/wjg.v23.i4.712.
6
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
Hepatology. 2017 Jun;65(6):2090-2099. doi: 10.1002/hep.29055. Epub 2017 Apr 28.
7
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Hepatol Res. 2017 Apr;47(5):405-418. doi: 10.1111/hepr.12762. Epub 2016 Jul 24.
9
Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
World J Gastroenterol. 2016 Apr 28;22(16):4091-108. doi: 10.3748/wjg.v22.i16.4091.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验